{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:18:59Z","timestamp":1787872739288,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Chao-Yang Hospital Golden Seeds Foundation","award":["CYJZ202210"],"award-info":[{"award-number":["CYJZ202210"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52439-1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:22:53Z","timestamp":1779351773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atherogenic index of plasma as a predictor of cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries"],"prefix":"10.1038","volume":"16","author":[{"given":"Side","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhuang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"1","key":"52439_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach, F. et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 41 (1), 111\u2013188 (2020).","journal-title":"Eur. Heart J."},{"issue":"4","key":"52439_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/dc16-1958","volume":"40","author":"JS Lee","year":"2017","unstructured":"Lee, J. S. et al. Triglyceride and HDL-C dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: The Strong Heart Study. Diabetes Care 40(4), 529\u2013537 (2017).","journal-title":"Diabetes Care"},{"issue":"5","key":"52439_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas, J. C. et al. Atherogenic index of plasma: Novel predictive biomarker for cardiovascular illnesses. Arch. Med. Res. 50(5), 285\u2013294 (2019).","journal-title":"Arch. Med. Res."},{"issue":"1","key":"52439_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12944-018-0656-1","volume":"17","author":"SW Shen","year":"2018","unstructured":"Shen, S. W. et al. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 17 (1), 11 (2018).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"52439_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-021-01377-5","volume":"20","author":"J Kim","year":"2021","unstructured":"Kim, J. et al. Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults. Cardiovasc. Diabetol. 20 (1), 183 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"52439_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-89307-z","volume":"11","author":"YW Li","year":"2021","unstructured":"Li, Y. W. et al. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: A 9-year longitudinal study. Sci. Rep. 11(1), 9900 (2021).","journal-title":"Sci. Rep."},{"issue":"9","key":"52439_CR7","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1080\/00015385.2020.1858537","volume":"76","author":"M Gentile","year":"2021","unstructured":"Gentile, M. et al. Association between atherogenic index of plasma and carotid intima-media thickness in a cohort of Mediterranean women. Acta Cardiol. 76(9), 987\u2013992 (2021).","journal-title":"Acta Cardiol."},{"issue":"1","key":"52439_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12944-020-01317-4","volume":"19","author":"JS Nam","year":"2020","unstructured":"Nam, J. S. et al. Association between atherogenic index of plasma and coronary artery calcification progression in Korean adults. Lipids Health Dis. 19 (1), 157 (2020).","journal-title":"Lipids Health Dis."},{"issue":"12","key":"52439_CR9","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/clc.23450","volume":"43","author":"KB Won","year":"2020","unstructured":"Won, K. B. et al. Atherogenic index of plasma and the risk of advanced subclinical coronary artery disease beyond traditional risk factors: An observational cohort study. Clin. Cardiol. 43(12), 1398\u20131404 (2020).","journal-title":"Clin. Cardiol."},{"issue":"2","key":"52439_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0003319720949804","volume":"72","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX score. Angiology 72(2), 181\u2013186 (2021).","journal-title":"Angiology"},{"key":"52439_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0222-7","volume":"15","author":"JR Nansseu","year":"2016","unstructured":"Nansseu, J. R. et al. Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women. Lipids Health Dis. 15, 49 (2016).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"52439_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12933-021-01393-5","volume":"20","author":"L Fu","year":"2021","unstructured":"Fu, L. et al. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc. Diabetol. 20 (1), 201 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"52439_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.amjms.2017.03.032","volume":"354","author":"SH Yang","year":"2017","unstructured":"Yang, S. H. et al. Triglyceride to high-density lipoprotein cholesterol ratio and cardiovascular events in diabetics with coronary artery disease. Am. J. Med. Sci. 354(2), 117\u2013124 (2017).","journal-title":"Am. J. Med. Sci."},{"key":"52439_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.718604","volume":"8","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Predictive value of the triglyceride to high-density lipoprotein cholesterol ratio for all-cause mortality and cardiovascular death in diabetic patients with coronary artery disease treated with statins. Front. Cardiovasc. Med. 8, 718604 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"52439_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12933-020-0989-8","volume":"19","author":"Z Qin","year":"2020","unstructured":"Qin, Z. et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: Results from an observational cohort study in China. Cardiovasc. Diabetol. 19(1), 23 (2020).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"52439_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12944-020-01418-0","volume":"19","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention. Lipids Health Dis. 19 (1), 240 (2020).","journal-title":"Lipids Health Dis."},{"issue":"8","key":"52439_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.5551\/jat.63136","volume":"29","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors. J. Atheroscler Thromb. 29 (8), 1226\u20131235 (2022).","journal-title":"J. Atheroscler Thromb."},{"issue":"3","key":"52439_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/eurheartj\/ehw149","volume":"38","author":"S Agewall","year":"2017","unstructured":"Agewall, S. et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur. Heart J. 38 (3), 143\u2013153 (2017).","journal-title":"Eur. Heart J."},{"issue":"18","key":"52439_CR19","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","volume":"139","author":"JE Tamis-Holland","year":"2019","unstructured":"Tamis-Holland, J. E. et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: A scientific statement from the American Heart Association. Circulation 139(18), e891-908 (2019).","journal-title":"Circulation"},{"issue":"8","key":"52439_CR20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/eurheartj\/ehu469","volume":"36","author":"G Niccoli","year":"2015","unstructured":"Niccoli, G., Scalone, G. & Crea, F. Acute myocardial infarction with no obstructive coronary atherosclerosis: Mechanisms and management. Eur. Heart J. 36(8), 475\u2013481 (2015).","journal-title":"Eur. Heart J."},{"key":"52439_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijcard.2018.04.004","volume":"264","author":"KR Bainey","year":"2018","unstructured":"Bainey, K. R. et al. Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. Int. J. Cardiol. 264, 12\u201317 (2018).","journal-title":"Int. J. Cardiol."},{"issue":"13","key":"52439_CR22","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009174","volume":"7","author":"B Safdar","year":"2018","unstructured":"Safdar, B. et al. Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): Results from the VIRGO Study. J. Am. Heart. Assoc. 7(13), e009174 (2018).","journal-title":"J. Am. Heart. Assoc."},{"issue":"2","key":"52439_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/eurheartj\/ehx491","volume":"39","author":"HB Andersson","year":"2018","unstructured":"Andersson, H. B. et al. Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease. Eur. Heart J. 39 (2), 102\u2013110 (2018).","journal-title":"Eur. Heart J."},{"issue":"3","key":"52439_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/CIRCINTERVENTIONS.113.000606","volume":"7","author":"D Planer","year":"2014","unstructured":"Planer, D. et al. Prognosis of patients with non-ST-segment-elevation myocardial infarction and nonobstructive coronary artery disease: propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circ. Cardiovasc. Interv. 7 (3), 285\u2013293 (2014).","journal-title":"Circ. Cardiovasc. Interv"},{"key":"52439_CR25","doi-asserted-by":"publisher","first-page":"e024366","DOI":"10.1161\/JAHA.121.024366","volume":"11","author":"S Gao","year":"2022","unstructured":"Gao, S. et al. Remnant Cholesterol Predicts Risk of Cardiovascular Events in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries. J. Am. Heart Assoc. 11, e024366 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"52439_CR26","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth Universal Definition of Myocardial Infarction (2018). J. Am. Coll. Cardiol. 72, 2231\u20132264 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"52439_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jacc.2017.12.048","volume":"71","author":"KA Hicks","year":"2018","unstructured":"Hicks, K. A. et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. J. Am. Coll. Cardiol. 71, 1021\u20131034 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"52439_CR28","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1002\/sim.5777","volume":"32","author":"H Ma","year":"2013","unstructured":"Ma, H. et al. On use of partial\u2002area\u2002under\u2002the ROC\u2002curve\u2002for evaluation of diagnostic performance. Stat. Med. 32, 3449\u20133458 (2013).","journal-title":"Stat. Med."},{"issue":"9753","key":"52439_CR29","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent, C. et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376 (9753), 1670\u20131681 (2010).","journal-title":"Lancet"},{"issue":"5","key":"52439_CR30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jacl.2017.06.015","volume":"11","author":"ND Wong","year":"2017","unstructured":"Wong, N. D. et al. Residual atherosclerotic cardiovascular disease risk in statin-treated adults: The Multi-Ethnic Study of Atherosclerosis. J. Clin. Lipidol. 11 (5), 1223\u20131233 (2017).","journal-title":"J. Clin. Lipidol."},{"issue":"21","key":"52439_CR31","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1016\/j.jacc.2015.03.543","volume":"65","author":"PH Joshi","year":"2015","unstructured":"Joshi, P. H., Martin, S. S. & Blumenthal, R. S. The remnants of residual risk. J. Am. Coll. Cardiol. 65(21), 2276\u20132278 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"52439_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/MED.0000000000000468","volume":"26","author":"G Generoso","year":"2019","unstructured":"Generoso, G., Janovsky, C. C. P. S. & Bittencourt, M. S. Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis. Curr. Opin. Endocrinol. Diabetes Obes. 26(2), 109\u2013116 (2019).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"9943","key":"52439_CR33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader, D. J. & Hovingh, G. K. HDL and cardiovascular disease. Lancet 384(9943), 618\u2013625 (2014).","journal-title":"Lancet"},{"issue":"11","key":"52439_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman, M. J. et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: Evidence and guidance for management. Eur. Heart J. 32(11), 1345\u20131361 (2011).","journal-title":"Eur. Heart J."},{"issue":"1","key":"52439_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12944-021-01496-8","volume":"20","author":"H Huang","year":"2021","unstructured":"Huang, H. et al. Atherogenic index of plasma is related to coronary atherosclerotic disease in elderly individuals: A cross-sectional study. Lipids Health Dis. 20(1), 68 (2021).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"52439_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12933-025-02582-2","volume":"24","author":"R Assempoor","year":"2025","unstructured":"Assempoor, R. et al. Atherogenic index of plasma and coronary artery disease: A systematic review and meta-analysis of observational studies. Cardiovasc. Diabetol. 24(1), 35. (2025).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"52439_CR37","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12933-024-02532-4","volume":"23","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. The relationship between atherogenic index of plasma and plaque vulnerabilities: An optical coherence tomography study. Cardiovasc. Diabetol. 23(1), 442 (2024).","journal-title":"Cardiovasc. Diabetol."},{"issue":"11","key":"52439_CR38","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jcin.2025.04.044","volume":"18","author":"FG Biccir\u00e8","year":"2025","unstructured":"Biccir\u00e8, F. G. et al. Long-term prognostic impact of OCT-derived high-risk plaque features: Extended follow-up of the CLIMA study. JACC Cardiovasc. Interv. 18(11), 1361\u20131372 (2025).","journal-title":"JACC Cardiovasc. Interv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52439-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52439-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:54:12Z","timestamp":1787871252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52439-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52439"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52439-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26988"}}